Ushbu ish iqtibos qilgan ishlar

144 ta ish

Ish: New approaches of chimeric antigen receptor (CAR)-immune cell-based therapy in gastric cancer; highlight CAR-T and CAR-NK

A view on drug resistance in cancer
Neil Vasan, José Baselga, David M. Hyman
Sharh maqola20197 iqtibos
ABI
The Proceedings of the National Academy of Sciences
Jos W. Richards
Maqola19155 iqtibos
ABI
Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Parisa Karimi, Farhad Islami, Sharmila Anandasabapathy +2
Sharh maqola20144 iqtibos
ABI
Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
Diana Gumber, Leo D. Wang
Sharh maqola20224 iqtibos
ABI
Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer
Bihui Cao, Manting Liu, Jingjun Huang +17
Maqola20213 iqtibos
ABI
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
Changsong Qi, Jifang Gong, Jian Li +23
Maqola20223 iqtibos
ABI
Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance
Yanping Yang, Raymond H. Y. Louie, Janusz Puc +6
Maqola20233 iqtibos
ABI
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu +3
Sharh maqola20223 iqtibos
ABI
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain, Renier J. Brentjens, Isabelle Rivière
Sharh maqola20133 iqtibos
ABI
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
Mohamed-Reda Benmebarek, Clara H. Karches, Bruno L. Cadilha +3
Sharh maqola20192 iqtibos
ABI
HER2-specific chimeric antigen receptor-engineered natural killer cells combined with apatinib for the treatment of gastric cancer
Xian Wu, Shucheng Huang
Maqola20192 iqtibos
ABI
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh +4
Sharh maqola20232 iqtibos
ABI
Development of NK cell-based cancer immunotherapies through receptor engineering
Audrey Page, Nicolas Chuvin, Jenny Valladeau‐Guilemond +1
Maqola20242 iqtibos
ABI
Engineering CAR-NK cell derived exosome disguised nano-bombs for enhanced HER2 positive breast cancer brain metastasis therapy
Bolong Tao, Ruoxin Du, Xiangmei Zhang +4
Maqola20232 iqtibos
ABI
Emerging roles of circular RNAs in gastric cancer metastasis and drug resistance
Xiaolin Wang, Jiahui Zhang, Guozhen Cao +3
Sharh maqola20222 iqtibos
ABI
FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1/NRF2 signaling pathway
Yunjiang Zhou, Yaxin Chen, Yongwei Shi +6
Maqola20232 iqtibos
ABI
CircRNA: A new class of targets for gastric cancer drug resistance therapy
Ying Zheng, Zhe Li, Yao Wang +4
Sharh maqola20232 iqtibos
ABI
Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
Jiahua Liu, Qihang Yuan, Hui Guo +3
Maqola20242 iqtibos
ABI
Early Tumor–Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer
Ryul Kim, Minae An, Hyuk Lee +13
Maqola20212 iqtibos
ABI
Sarlavhasiz
Boshqa2 iqtibos
ABI
Gastric cancer treatment: recent progress and future perspectives
Wen‐Long Guan, Ye He, Rui‐Hua Xu
Sharh maqola20232 iqtibos
ABI
CAR-NK cells for cancer immunotherapy: recent advances and future directions
Tianye Li, Mengke Niu, Weijiang Zhang +3
Maqola20242 iqtibos
ABI
Cancer immunoediting: from immunosurveillance to tumor escape
Gavin P. Dunn, Allen T. Bruce, Hiroaki Ikeda +2
Sharh maqola20022 iqtibos
ABI
Tumour heterogeneity and the evolution of polyclonal drug resistance
Rebecca A. Burrell, Charles Swanton
Sharh maqola20142 iqtibos
ABI
Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo
Yanjing Song, Chuan Tong, Yao Wang +8
Maqola20172 iqtibos
ABI